This report contains market size and forecasts of Uterine Fibroid Treatment in Global, including the following market information:
Global Uterine Fibroid Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Uterine Fibroid Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Endometrial Ablation Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Uterine Fibroid Treatment include Blue Endo, Boston Scientific Corporation, CooperSurgical, Inc., KARL STORZ SE & Co. KG, Myovant Sciences (Sumitovant Biopharma Ltd.), Halt Medical, Inc., LiNA Medical USA, Merit Medical Systems and Olympus Corporation and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Uterine Fibroid Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Uterine Fibroid Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Uterine Fibroid Treatment Market Segment Percentages, by Type, 2021 (%)
Endometrial Ablation
MRI Guided Procedures
Hysterectomy
Myomectomy
Uterine Artery Embolization
Radiofrequency Ablation
Others
Global Uterine Fibroid Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Uterine Fibroid Treatment Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Other
Global Uterine Fibroid Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Uterine Fibroid Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Uterine Fibroid Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Uterine Fibroid Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Blue Endo
Boston Scientific Corporation
CooperSurgical, Inc.
KARL STORZ SE & Co. KG
Myovant Sciences (Sumitovant Biopharma Ltd.)
Halt Medical, Inc.
LiNA Medical USA
Merit Medical Systems
Olympus Corporation
Richard Wolf GmbH